REFERENCES
- Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244–50, 2003.
- de Jong J, Stopp H, Dohle GR, Bangma CH, Kliffen M, van Esser JWJ, van den Bent M, Kros JM, Oosterhuis JW, Looijenga LH. Diagnostic Value of OCT3/4 for pre-invasive and invasive testicular germ cell tumors. J Pathol 206:242–9, 2005.
- Jones TD, Ulbright TM, Eble JN, Baldridge L, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 28:935–40, 2004.
- Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10:8544–7, 2004.
- Beltran AS, Rivenbark AG, Richardson BT, Yuan X, Quian H, Hunt JP, Zimmerman E, Graves LM, Blancafort P. Generation of tumor initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Research 13:R94, 2011.
- MD Anderson Cancer Center. 2011. “Germ Cell Tumors-Childhood”. The University of Texas. December 10, 2011. <http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/childhood-germ-cell-tumors/index.html>
- Van Casteren NJ, Stoop H, Dohle GR, Wit R, Oosterhuis JW, Looijenga LH. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. European Urology 54;153–60, 2008.